Literature DB >> 23806825

Procalcitonin ratio as a predictor of successful surgical treatment of severe necrotizing soft tissue infections.

Jan Friederichs1, Martin Hutter, Christian Hierholzer, Alexander Novotny, Helmut Friess, Volker Bühren, Sven Hungerer.   

Abstract

BACKGROUND: Necrotizing soft tissue infections often are characterized by fulminant presentation and lethal outcomes. Besides critical care support and antibiotic therapy, aggressive surgical treatment is important for the therapy of necrotizing fasciitis. The aim of this study was to develop a procalcitonin (PCT) ratio indicating successful surgical intervention.
METHODS: The study group consisted of 38 patients treated with clinical signs of sepsis caused by a necrotizing soft tissue infection. All patients received radical surgical treatment, and serum levels of PCT and C-reactive protein were monitored postoperatively. The ratio of day 1 to day 2 was calculated and correlated with the successful elimination of the infectious source and clinical recovery.
RESULTS: An eradication of the infectious focus was successfully performed in 84% of patients, averaging 1.9 operations (range 1 to 6) to achieve an elimination of the infectious source. The PCT ratio was significantly higher in the group of patients with successful surgical intervention (1.665 vs .9, P < .001). A ratio higher than the calculated cutoff of 1.14 indicated successful surgical treatment with a sensitivity of 83.3% and a specificity of 71.4%. The positive predictive value was 75.8%, and the negative predictive value was 80.0%.
CONCLUSIONS: The PCT ratio of postoperative day 1 to day 2 following major surgical procedures for necrotizing soft tissue infections represents a valuable clinical tool indicating successful surgical eradication of the infectious focus.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Necrotizing fasciitis; Necrotizing soft tissue infection; Procalcitonin

Mesh:

Substances:

Year:  2013        PMID: 23806825     DOI: 10.1016/j.amjsurg.2012.11.024

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  17 in total

1.  Necrotising soft tissue infection in a UK metropolitan population.

Authors:  G E Glass; F Sheil; J C Ruston; P E M Butler
Journal:  Ann R Coll Surg Engl       Date:  2015-01       Impact factor: 1.891

2.  The Prediction Predicament: Rethinking Necrotizing Soft Tissue Infections Mortality.

Authors:  Samantha A Moore; Brandon H Levy; Chalani Prematilake; Sharmila Dissanaike
Journal:  Surg Infect (Larchmt)       Date:  2015-08-10       Impact factor: 2.150

3.  Procalcitonin ratio and on-demand relaparotomy for septic peritonitis: validation of the focus index (FI).

Authors:  Volker Assfalg; Petra Wolf; Daniel Reim; Norbert Hüser; Georg Hellbrügge; Edouard Matevossian; Helmut Friess; Bernhard Holzmann; Klaus L Emmanuel; Alexander R Novotny
Journal:  Surg Today       Date:  2015-07-27       Impact factor: 2.549

4.  Pneumoretroperitoneum and Pneumomediastinum Revealing a Left Colon Perforation.

Authors:  Giulia Montori; Giacomo Di Giovanni; Zeineb Mzoughi; Cedric Angot; Sophie Al Samman; Leonardo Solaini; Nicolas Cheynel
Journal:  Int Surg       Date:  2015-06

Review 5.  Update on procalcitonin measurements.

Authors:  Michael Meisner
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

Review 6.  Procalcitonin-guided diagnosis and antibiotic stewardship revisited.

Authors:  Ramon Sager; Alexander Kutz; Beat Mueller; Philipp Schuetz
Journal:  BMC Med       Date:  2017-01-24       Impact factor: 8.775

Review 7.  Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit.

Authors:  John Alfred Carr
Journal:  J Intensive Care       Date:  2015-08-04

Review 8.  Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians.

Authors:  Anurag Markanday
Journal:  Open Forum Infect Dis       Date:  2015-07-03       Impact factor: 3.835

9.  Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study.

Authors:  Nonika Rajkumari; Purva Mathur; Satyapriya Sharma; Babita Gupta; Sanjeev Bhoi; Mahesh C Misra
Journal:  J Lab Physicians       Date:  2013-07

10.  Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.

Authors:  Marco Bo Hansen; Lars Simon Rasmussen; Peter Garred; Daniel Bidstrup; Martin Bruun Madsen; Ole Hyldegaard
Journal:  Crit Care       Date:  2016-02-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.